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The role of the CD11c+ cell Tsc1-mTORC1 nutrient sensing 
pathway in metabolic homeostasis. 
By. Danai Nyasha Chagwedera 
 
Abstract  
Alterations in host metabolic state have been reported to drastically alter gut microbial 
communities and influence host immune responses. While much attention has been paid to how 
the gut microbiome affects immune cell response, the reverse is understudied: how do immune 
cells influence the gut microbiome and in turn, regulate host metabolic state? CD11c+ cells are 
well known for their critical role in bridging innate and adaptive immune responses and are 
resident cells of almost all tissues in the body. In the gut, CD11c+ cells are located in the lamina 
propria and have been shown to play a key role in maintaining gut immune homeostasis. The 
tuberous sclerosis 1 - mechanistic target of rapamycin complex 1 (Tsc1-mTORC1) pathway is a 
cell’s major nutrient-sensing pathway and functions to assess nutrient availability and determine 
whether energy-intensive processes, such as protein translation, should take place. Specifically, 
Tsc1 is a negative regulator of mTORC1 and inhibits mTOR activity under conditions of low 
nutrient availability. Given this knowledge, we asked whether perturbing nutrient sensing in 
CD11c+ cells would alter the gut microbiome to ultimately influence host systemic metabolism. 
We generated CD11cCre x Tsc1flox/flox mice (C57BL/6J background), where Tsc1 was specifically 
deleted in all CD11c expressing cells. Tsc1flox/flox (“control; CTRL”) and CD11cCre x Tsc1flox/flox 
(“knockout; KO”) mice were housed under thermoneutral (30°C) and sub-thermoneutral 
conditions (22°C), and placed on normal chow diet (NCD) or high-fat diet (HFD). Weight gain, 
 ix 
glucose and insulin sensitivity, and food intake were monitored over time. Additionally stool was 
collected for 16S rRNA gene sequencing. First, we determined how nutrient sensing by immune 
cells regulates body weight, adiposity and insulin action. Under all housing conditions, KO mice 
exhibited reduced weight gain as compared to CTRL mice. This decrease in body weight was not 
due to growth or birth defects and persisted with age. Analysis of food intake uncovered a 
reduction in overall food consumption. There were no differences in metabolic rate or physical 
activity between the groups. Interestingly, on a HFD protection from insulin resistance only 
occurred under thermoneutral conditions. In addition, we have investigated the microbial and 
immunologic mechanisms by which alterations in nutrient sensing in immune cells regulates 
weight gain. Flow cytometric analyses of immune cell populations in the small intestine and colon 
revealed differences in IgA binding. Co-housing experiments identified KO as capable of gaining 
weight in the presence of the CTRL mouse microbiome. We therefore show that activation of 
nutrient sensing pathways in CD11c+ cells is sufficient to modulate systemic metabolism through 
alterations in the gut microbiome and that housing temperature conditions affects insulin and the 
microbiome. This project furthers our understanding of the role immune cells play in regulating 
systemic metabolism and has immediate translational implications for the treatment of metabolic 
disorders. 
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CHAPTER 1: INTRODUCTION 
 1 
How is energy balance and weight gain controlled? In 1953 Kennedy proposed a unique system 
where by the brain is informed of available energy stores via circulating signals and in response 
to these signals adjusts food intake (Kennedy, 1953). This is known as the energy homeostasis 
system and is composed of signals to the brain that determine whether, when and how much to 
eat. The neurocircuitry in the brain is composed of orexigenic and anorexigenic hypothalamic 
neurons expressing agouti-related protein (AGRP) and pro-opiomelanocortin (POMC).  We now 
know that many factors feed in to this neurocircuitry. These factors can be broadly dived into 
adiposity signals (leptin and insulin), gut peptides, (PYY, GLP-1, CCK, ghrelin), nutrients and 
even pro-inflammatory cytokines (interleukin-6 and tumor necrosis factor-α) (Figure 1.1) 
(Morton et al., 2014). Although there are many factors known to contribute to this energy 
homeostasis circuit, our understanding of this is not complete, in particular the role the immune 
system plays in regulating energy homeostasis and weight control under normal non-obese 
conditions is a mystery.  
A recent explosion in the field of immunometabolism has given us a clue into the types of 
immune cells and pathways that play a role in regulating energy homeostasis in a diseased state. 
During obesity, significant changes occur in the epididymal fat pad that lead to metabolic 
dysregulation. Adipocyte cells hypertrophy, leading to local hypoxia and a significant change in 
the immune cell milieu, in particular an infiltration of Th1 CD4+ T,  B,  CD8+ T, mast cells, 
macrophages (CD11c+) and neutrophils (Figure 1.2) (Lackey and Olefsky, 2016) .  
Although many immune cells have been shown to contribute to high-fat diet induced 
metabolic dysfunction, none are as instrumental as the CD11c+ cell.  CD11c is traditionally 
thought of as a being on the surface of macrophages and dendritic cells (Abram  et al., 2014), 
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although in CD11c-cre mice, some deletion has been shown in populations of monocytes, NK 
cells as well as low level, non-specific deletion in T and B cells. 
The role of CD11c+ cells in high-fat diet induced metabolic dysfunction is instrumental - 
up to 40% of resident cells in obese tissue can be CD11c positive. CD11c+ macrophages are 
specifically recruited to adipose tissue when mice are exposed to a high-fat diet (Lumeng et al., 
2007; Nguyen et al., 2007). These CD11c+ cells are pro-inflammatory, expressing IL-1β, IL-6, 
TNF-α and CCR2, leading to subsequent low-grade inflammation induced insulin resistance 
(Greenberg and Obin, 2006; Shoelson et al., 2006). Ablation of CD11c+ cells using CD11c-DTR 
mice results in normalization of insulin sensitivity and a decrease in local and systemic 
inflammatory makers (Patsouris et al., 2008). Additionally, under homeostatic conditions, 
CD11c is also found on the surface of a small number of microglia – the main immune cells of 
brain (Immig et al., 2015; Prodinger et al., 2011; Wlodarczyk et al., 2014). Microglia play an 
important role in regulating food consumption and weight gain through modulation of 
hypothalamic inflammation (Thaler et al., 2013; Valdearcos et al., 2017).  
Given the important roles of CD11c+ cells in energy homeostasis and weight gain we 
asked what the effect of altering a metabolic pathway in CD11c+ cells would be on systemic 
metabolism. In particular we specifically deleted Tsc1 in CD11c+ cells by creating a Tsc1f/f x 
CD11cCre mouse. 
The Tsc1-mTORC1 pathway is a central regulator of cell metabolism (Figure 1.3). The 
tuberous sclerosis complex 1 is a negative regulator of mammalian target of rapamycin complex 
1. Activation of the Tsc1-mTORC1 pathway results in energy requiring processes such as protein 
translation, cell growth and metabolism to occur. The Tsc1-mTORC1 pathway has recently 
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emerged as playing an important role in CD11c+ cell biology (Shimobayashi and Hall, 2014; 
Laplante et al., 2012; Weichhart et al., 2015). 
Activation of mTORC1 in CD11c+ cells by targeted deletion of Tsc1 (Tsc1f/f CD11cCre) 
affects CD11c+ cell function, maturation and differentiation (Amiel et al., 2014; Luo et al., 2017; 
Pan et al., 2013; Sathaliyawala et al., 2010; Sukhbaatar et al., 2016; Wang and Res, 2014). Tsc1 
ablation in CD11c+ cells results in upregulation of genes involved in cell survival, proliferation, 
metabolism (Luo et al., 2018). Three studies have examined the functional role of Tsc1 in 
CD11c+ cells in vivo.  The diversity of their findings points to the complexity and importance of 
the Tsc1-mTORC1 pathway in CD11c+ cells. Pan et al show Tsc1-deficient CD11c+ cells have 
defective antigen presentation to CD4+ T cells due to altered cytokine expression and impaired 
CIITA/MHC-II expression (Pan et al., 2013). Wang et al demonstrated a disruption in dendritic 
cell development resulting in reduced numbers in mesenteric lymph node, liver and kidney 
CD11c+ cells. They also observed decreased IL-12p35 production resulting in reduced 
Th1stimulation, despite elevated maturation markers (CD86, CD80, CD40) (Wang et al., 2013). 
Luo et al did not detect alterations in co-stimulatory molecules, differentiation or cytokine 
expression but did note defective antigen-specific response both in vitro and in vivo. In addition, 
they observed characteristics of autoimmunity such as increased naïve T cell proliferation, 
splenomegaly, lymphadenopathy, increased serum immunoglobin levels and weight loss (Luo et 
al., 2017). 
Although our initial studies of CD11c+ cells were motivated by the role of CD11c+ cells 
in obese animals we found to our surprise that the phenotype of reduced weight gain in 
Tsc1f/fCD11cCre mice was independent of high-fat diet and thus CD11c+ cells in epididymal fat 
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pads. We therefore turned out attention to other areas in the body where CD11c+ cells are present 
and could impact systemic metabolism.  
In the intestine, CD11c is expressed on mononuclear phagocytes (MPs) which comprise 
both macrophages and dendritic cells (Bradford et al., 2011; Cerovic et al., 2014) (Figure 1.4). 
MPs can affect the intestinal microbial composition and gut homeostasis  in several ways. 
Intestinal dendritic cells sample luminal content via specialized microfold M cells, through 
extension of protrusions through the epithelial layer or via transport of luminal antigen in goblet 
cells (Farache et al., 2013). Intestinal macrophages can sample luminal content via transepithelial 
dendrites (Chieppa et al., 2006; Niess et al., 2005). Once the antigen is acquired, MP’s can 
trigger the innate and adaptive immune response. CD103+ DCs have a unique ability to induce a 
tolerogenic response by migrating to the mesenteric lymph node and inducing differentiation of 
Foxp3+ T regulatory (Treg) cells (Sun et al., 2007; Coombes et al., 2007). In addition, 
macrophages play an important role in maintenance and secondary expansion of these Tregs 
(Hadis et al., 2011). Macrophages also play a key role in supporting gut barrier integrity (Pull et 
al., 2005; Qualls et al., 2006). This is evidenced by the fact that CD11c+ cells deficient in 
mTORC1 activity have reduced IL-10 secretion and are highly susceptible to dextran sodium 
sulfate-induced colitis (Ohtani et al., 2012). Finally, macrophages possess a high phagocytic and 
bactericidal activity that can directly clear microbes (Müller et al., 2012). These roles 
collectively have a great effect on the microbiome which led us to hypothesize that CD11c+ cells 
were altering the microbiome in our model which in turn was regulating energy homeostasis.  
Several key studies have shown that the gut microbiome regulation of host energy 
homeostasis and weight gain. The first observation that the microbiome modulates host 
metabolism came from Bäckhead et al who showed that within 14 days of colonization, germ-
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free mice had a 60% increase in body fat content and developed insulin resistance (Bäckhed et 
al., 2004). It was then appreciated that obesity drastically alters the gut microbiome composition 
and Turnbaugh et al showed that microbiota from obese mice was sufficient to confer weight 
gain to germ-free recipient mice (Ley et al., 2005; Turnbaugh et al., 2006). These seminal 
observations, have led to an understanding of the mechanisms by which the microbiome 
regulates host metabolism. Directly, the microbiome can alter host metabolism by regulating 
fermentation and energy harvest from food. Indirectly, microbial products such as 
lipopolysaccharides, peptidoglycan, bile acids and short-chain fatty acids can affect the liver, 
brain, muscle and adipose tissue which subsequently influence host metabolism (Tremaroli and 
Nature, 2012).  
This dissertation connects the worlds of immunology, metabolism and the microbiome. 
Here, we examine the effect of altering the central regulator of metabolism Tsc1-mTORC1 
pathway in CD11c+ cells on systemic metabolism. Our findings provide evidence that altering 
immune cell metabolism is sufficient to alter host systemic metabolism through specific changes 
in gut microbiome populations.  
  
 6 
FIGURES 
Figure 1.1 The energy homeostasis system connects to neurocircuitry to control food intake. 
Peptide YY (PYY) and ghrelin feed in to orexigenic neuron Agouti-related Peptide (AgRP). 
Leptin, insulin, pro-inflammatory cytokines, nutrients, Glucagon-Like Peptide-1 (GLP-1), and 
Cholecystokinin (CCK) all feed into anorexigenic neuron Pro-opiomelanocortin (POMC). AgRP 
and POMC neurons stimulate effector neurons in the Paraventricular nucleus (PVN).  
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Figure 1.2 Immune cell and adipocyte changes when moving from lean to obese state. In the lean 
state anti-inflammatory cytokines from resident immune cells and alternatively-activated 
macrophages (AAM) promote insulin sensitivity. In the obese state adipocytes hypertrophy 
causing hypoxia. CD11c+ cells, also called classically-activated macrophages (CAMs) infiltrate 
the fat pads and secrete pro-inflammatory cytokines which leads to insulin-resistance.  
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Figure 1.3 The Tsc1-mTORC1 pathway. Nutrients, growth factors and energy activate the Tsc1-
mTORC1 pathway. Tuberous Sclerosis Protein 1 (Tsc1) forms a heterodimer with Tsc2 and 
together they inhibit Ras Homolog Enriched in Brain (Rheb) bound GTP – an activator of 
mammalian target of rapamycin complex 1 (mTORC1). Activated mTORC1 promotes protein 
synthesis and inhibits autophagy to promote cell growth, division and differentiation in response 
to the available energy.  
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Figure 1.3 The Tsc1-mTORC1 pathway.   
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Figure 1.4 Role of macrophages and dendritic cells in the intestine. CD11c is found on the 
surface of both macrophages and dendritic cells in the intestine. Intestinal macrophages (left) 
engulf invading bacteria, maintain epithelial barrier integrity and support secondary expansion of 
T regulatory (Treg) cells. Dendritic cells (right) use dendrites to sample luminal contents and 
then migrate to the mesenteric lymph node where they stimulate the appropriate T-cell response.  
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Nutrient sensing in CD11c cells alters the gut microbiome to 
regulate food intake and body mass. 
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ABSTRACT 
Microbial dysbiosis and inflammation are implicated in the pathogenesis of diet-induced 
obesity and insulin resistance. However, it is not known whether crosstalk between immunity 
and the microbiome also regulates metabolic homeostasis in healthy animals. Here, we report 
that genetic deletion of Tsc1 in CD11c cells (Tsc1f/fCD11cCre mice) reduced food intake and 
body mass in the absence of metabolic disease. Cohousing and fecal transplant experiments 
revealed a dominant role for the host microbiome in regulation of body weight. 16S rRNA 
sequencing, selective culture, and reconstitution experiments further confirmed that selective 
deficiency of Lactobacillus strain Q1-7 contributed to decreased food intake and body mass in 
Tsc1f/fCD11cCre mice. Mechanistically, activation of mTORC1 signaling in CD11c cells 
regulated production of Lactobacillus strain Q1-7-specific IgA, allowing for its stable 
colonization in the gut. Together, our findings reveal an unexpected transkingdom immune-
microbiome feedback loop for homeostatic regulation of food intake and body mass in mammals.  
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INTRODUCTION 
Hypothalamic circuits regulate caloric intake, meal size, and energy expenditure to 
maintain body weight within a narrow range (Morton et al., 2014; Waterson and Horvath, 2015). 
This is principally mediated by the crosstalk between orexigenic and anorexigenic hypothalamic 
neurons expressing agouti-related protein (AGRP) and pro-opiomelanocortin (POMC), 
respectively. Since the activity of these neurons can be modulated by hormones (leptin, insulin, 
and glucagon-like peptide 1 (GLP1)), nutrients (glucose and fatty acids), and inflammatory 
cytokines (interleukin-6 and tumor necrosis factor-α), it provides a mechanism for regulating 
food intake and body weight under diverse set of dietary and environmental conditions.  
In addition to these classical neuronal and hormonal pathways, previous studies in obese 
animals have implicated the immune system and the microbiome in regulation of body weight 
and insulin action (Heiss and Olofsson, 2018; Hotamisligil, 2017; Lee et al., 2018; Man et al., 
2017; Maruvada et al., 2017; Schroeder and Backhed, 2016; Sonnenburg and Backhed, 2016). 
For example, obesity is associated with accumulation of CD11c+ cells in white adipose tissue 
and microglial activation in the hypothalamus, which contribute to local and systemic 
inflammation, peripheral insulin resistance, and weight gain (Lumeng et al., 2007; Patsouris et 
al., 2008; Valdearcos et al., 2017). Moreover, in both mice and humans, dietary obesity alters the 
composition of the microbiome to increase energy harvest and systemic inflammation, factors 
which favor weight gain and insulin resistance, respectively (Ley et al., 2005; Nicholson et al., 
2012; Turnbaugh et al., 2009; Turnbaugh et al., 2006). While these studies in obese animals 
demonstrate a pathogenic role for inflammation and microbial dysbiosis in metabolic diseases, 
the physiologic importance of these transkingdom interactions in healthy animals remains less 
well understood.  
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Here, we tested the hypothesis that nutrient sensing in innate immune cells regulates 
energy balance under physiologic conditions. We found that genetic activation of mechanistic 
target of rapamycin complex 1 (mTORC1) in CD11c cells, as in Tsc1f/fCD11cCre mice, alters the 
gut microbiome to reduce food intake and body weight in lean mice. Because these metabolic 
phenotypes were transmissible by the microbiome, in particular by Lactobacillus strain Q1-7, our 
findings suggest existence of transkingdom immune-microbiome circuits for homeostatic 
regulation of food intake and body mass in healthy animals.  
RESULTS 
Activation of mTORC1 signaling in CD11c cells reduces body mass and food intake  
To investigate whether mTOR signaling in CD11c cells regulates glucose and energy 
homeostasis, we generated mice in which Tsc1, an inhibitor of the mTORC1 complex (Gonzalez 
and Hall, 2017; Saxton and Sabatini, 2017), was selectively deleted in CD11c cells (designated 
Tsc1f/fCD11cCre mice). Deletion of Tsc1 activated mTORC1 signaling in CD11c cells, as 
evidenced by increased phosphorylation of its downstream target S6 (Figure S1A-C). Although 
previous studies have implicated CD11c cells in pathogenesis of obesity-associated insulin 
resistance (Lumeng et al., 2007; Patsouris et al., 2008), nearly all of this work has been 
performed in animals housed under thermal stress conditions (ambient temperature (Ta) of 20-
22°C). Since we and others have reported that thermal stress has a profound effect on systemic 
metabolism (Cannon and Nedergaard, 2011; Ganeshan and Chawla, 2017; Gordon, 2017; Tian et 
al., 2016), we performed all of our studies with mice housed at thermoneutrality (Ta = 30°C). We 
observed that, compared to their littermate controls (Tsc1f/f mice), thermoneutral Tsc1f/fCD11cCre 
mice gained less weight on a high fat diet (Figure 1A), which was not associated with 
improvements in glucose tolerance or insulin sensitivity (Figure 1B, C). These results suggested 
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that the primary metabolic effects stemming from mTORC1 activation in CD11c cells were 
likely to be on body mass. To test this hypothesis, we repeated the studies with Tsc1f/f and 
Tsc1f/fCD11cCre mice that were fed a low-fat regular chow diet (24.5% protein, 13.1% fat, and 
62.3% carbohydrates). We again observed that Tsc1f/fCD11cCre mice had a lower body mass, 
which was independent of linear growth (Figure 1D and Figure S1D). Dual-energy X-ray 
absorptiometry (DEXA) revealed that reduction in both lean and fat mass contributed to the 
observed decrease in body mass in Tsc1f/fCD11cCre mice (Figure 1E). Based on these 
observations, we chose to study the systemic effects of mTORC1 activation in CD11c using 
mice that were fed a low-fat regular chow diet, which allowed us to avoid the pleiotropic effects 
of high fat diets on metabolic and immune systems, and the gut microbiome.  
To identify the underlying mechanisms for the observed decrease in body mass, we 
quantified changes in energy expenditure in Tsc1f/f and Tsc1f/fCD11cCre mice. We found that 
oxygen consumption and locomotor activity were similar in both groups of mice (Figure 1F, G 
and Figure S1E). Consistent with these observations, expression of thermogenic genes and 
thermogenic protein uncoupling protein 1 (UCP1) was not significantly different between the 
genotypes in brown adipose tissue (Figure S1F, G). We next asked whether deletion of Tsc1 in 
CD11c cells affected energy intake or absorption. Measurement of food intake revealed that food 
consumption was reduced by ∼22% in Tsc1f/fCD11cCre mice (Figure 1H), whereas bomb 
calorimetry revealed that energy harvest was similar in both groups of mice (Figure 1I). This 
observed reduction in food intake was independent of systemic inflammation, hypothalamic 
microglial activation, and intestinal histology, barrier function, and inflammation (Figure 1J, K 
and S2A-F), suggesting that other factors contribute to decreased food intake and smaller body 
mass in Tsc1f/fCD11cCre mice.  
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The microbiome of Tsc1f/fCD11cCre mice reduces food intake and body mass 
 The gut microbiome is an important factor that regulates energy homeostasis. In mice, 
maternal transfer of the microbiome occurs at birth, which undergoes diversification and 
stabilization as animals wean from breast milk to solid food (Stappenbeck and Virgin, 2016). 
Because we observed that body mass of Tsc1f/fCD11cCre mice diverged from their littermate 
controls shortly after weaning (Figure 2A), we postulated that differences in the structure and 
function of gut microbial communities found in Tsc1f/f and Tsc1f/fCD11cCre mice might 
contribute to energy homeostasis. In support of this hypothesis, when Tsc1f/f and Tsc1f/fCD11cCre 
mice were cohoused instead of being separated at weaning, body mass, body composition, and 
food intake were not significantly different between the genotypes (Figure 2B-D). These 
differences in food intake and body weight between separated and cohoused Tsc1f/f and 
Tsc1f/fCD11cCre mice could not be accounted for by variations in circulating levels of 
anorexigenic hormones leptin and GLP-1 (Figure S3A-C). These findings together suggested that 
the different microbial communities of Tsc1f/f and Tsc1f/fCD11cCre mice might contribute to the 
observed differences in food intake and body mass.  
 Principal Coordinates Analysis (PCoA) of 16S rRNA sequence variants using Bray-
Curtis dissimilarities revealed that microbial communities were compositionally distinct between 
Tsc1f/f and Tsc1f/fCD11cCre mice when they were housed separately (Figure 2E and Figure S3D). 
However, these differences in microbial composition disappeared when the two genotypes were 
cohoused (Figure 2E and Figure S3D), which coincided with lack of difference in body mass 
between the genotypes (Figure 2B). Furthermore, analysis of sequence variants across three 
replicate experiments revealed four clades, including Lactobacillaceae, Muribaculaceae, 
Lachnospiraceae and Ruminococcaceae, that were increased or decreased in Tsc1f/fCD11cCre 
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mice compared to Tsc1f/f mice (Figure 2F). Because the shifts in microbial composition 
paralleled the changes in food intake, it suggested a dominant role for the host microbiome in 
regulation of body mass. We tested this hypothesis by oral gavage of C57BL/6J mice, which 
were pretreated with antibiotics, with microbiota from Tsc1f/f or Tsc1f/fCD11cCre mice. We 
observed that C57BL/6J mice receiving microbiota from Tsc1f/fCD11cCre mice had lower food 
intake and body mass than those gavaged with microbiota from Tsc1f/f mice (Figure 2G, H). 
Together, these data suggest that Tsc1f/f and Tsc1f/fCD11cCre mice harbor distinct microbial 
communities, whose adoptive transfer into C57BL/6J mice is sufficient to alter food intake and 
body mass.  
Relative abundance of Lactobacillus johnsonii group is reduced in microbiota of 
Tsc1f/fCD11cCre mice 
 To narrow down the specific microbial taxa responsible for the regulation of the body 
mass in Tsc1f/fCD11cCre mice, we performed two types of microbiome chase experiments. First, 
we asked whether transfer of Tsc1f/f mice to dirty cages, which previously housed 
Tsc1f/fCD11cCre mice, affected weight gain in Tsc1f/f mice (Figure 3A). We observed that the rate 
of change in body mass and food intake was not significantly different between Tsc1f/f mice 
transferred to clean or Tsc1f/fCD11cCre dirty cages (Figure 3B, C). Second, we asked whether 
transfer of Tsc1f/fCD11cCre mice to cages that previously housed Tsc1f/f mice might promote an 
increase in body mass (Figure 3D). Compared to control mice, we found that the rate of weight 
gain and food intake increased when Tsc1f/fCD11cCre mice were transferred to dirty cages that 
previously housed Tsc1f/f mice (Figure 3E, F). Similar changes in body mass and food 
consumption were observed when Tsc1f/fCD11cCre mice were gavaged with donor microbiota 
from Tsc1f/f mice for 8 weeks (Figure 3G, H). Together, these data suggest that adoptive transfer 
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of Tsc1f/f microbiome is sufficient to rescue weight gain in Tsc1f/fCD11cCre mice, suggesting that 
chase or oral gavage might reconstitute microbes that are deficient in the microbiota of 
Tsc1f/fCD11cCre mice.  
 To identify the microbes whose abundance regulates food intake and body mass in 
Tsc1f/fCD11cCre mice, we used 16S rRNA sequencing to follow changes in microbial 
composition in Tsc1f/fCD11cCre mice subjected to the microbiome chase experimental paradigm. 
We found that 3 sequence variants assigned the taxonomic annotations Lactobacillus johnsonii 
group (species), Rikenellaceae RC9 group (genus), and Muribaculaceae group (family) were 
significantly different between microbiomes of Tsc1f/fCD11cCre mice that were transferred into 
clean cages or Tsc1f/f dirty cages (Figure 3D, 3I). However, Lactobacillus was the only clade that 
was reduced in microbiomes of Tsc1f/fCD11cCre mice that were housed separately after weaning 
(Figure 3J and Figure 2F). As multiple species could be mapped to these clades, we performed 
selective culture of Lactobacillus species followed by complete 16S rRNA sequencing of the 
isolated colonies. Based on the complete 16S rRNA sequence, the sequence variant of 
Lactobacillus that was cultured from stool of Tsc1f/f mice, referred here to as Lactobacillus strain 
Q1-7, taxonomically matched L. johnsonii (Figure S3E). This assignment to L. johnsonii was 
based on a 99% nucleotide identity match to L. johnsonii CIP 103620 (accession NR_117574.1). 
Furthermore, we found that the abundance of L. johnsonii group but not Rikenellaceae or 
Muribaculaceae increased over baseline in Tsc1f/fCD11cCre mice during the course of the chase 
experiment and declined when the microbial chase with feces from Tsc1f/f mice was stopped 
(Figure 3K and Figure S3F, G). These findings suggest that abundance of Lactobacillus strain 
Q1-7 might be causally linked to decreases in food intake and body mass observed in separately 
housed Tsc1f/fCD11cCre mice. 
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Reconstitution of Lactobacillus strain Q1-7 increases food intake and body mass in 
Tsc1f/fCD11cCre mice 
 We next asked whether reconstitution of Lactobacillus strain Q1-7 into Tsc1f/fCD11cCre 
mice can increase food intake and body mass. We found that when Tsc1f/fCD11cCre mice were 
gavaged with fecal contents supplemented with Lactobacillus strain Q1-7 (5x109 cfu), body mass 
and food intake increased progressively over a period of 5 weeks (Figure 4A, B). Quantitative 
PCR verified increased relative abundance of Lactobacillus in microbiota of Tsc1f/fCD11cCre 
mice (Figure 4C), indicating that oral introduction of Lactobacillus strain Q1-7 is sufficient to 
increase food intake and body mass in Tsc1f/fCD11cCre mice. Since previous studies have 
suggested a role for microbiome-derived short chain fatty acids (butyrate, acetate, and 
propionate) and metabolites (succinate) in food intake and glucose homeostasis in obese animals 
(De Vadder et al., 2016; Frost et al., 2014; Koh et al., 2016; Schroeder and Backhed, 2016), we 
performed targeted metabolomics on cecal, fecal, and plasma samples from Tsc1f/f and 
Tsc1f/fCD11cCre mice. Mass spectroscopy and NMR-based metabolomics revealed that levels of 
short chain fatty acids and other metabolites were largely similar in cecum, feces, and plasma of 
both groups of mice (Figure 4D and Figure S3H). These findings are consistent with our 
observations that energy extraction is similar in both genotypes (Figure 1I), suggesting that shifts 
in abundance of L. johnsonii group likely regulate food intake by other unknown mechanisms 
(Schroeder and Backhed, 2016). 
 We next asked how mTORC1 signaling in CD11c cells regulates abundance of 
Lactobacillus strain Q1-7 in the gut. To address this question, we began by characterizing 
intestinal immune cells because they are known to sample luminal contents to regulate intestinal 
immunity and microbial homeostasis (Ko and Chang, 2015). Using flow cytometry, we found 
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that numbers of various macrophage and dendritic cell subsets (both CD11c+ and CD11c-) and B 
cells were similar in the small intestines and colon of Tsc1f/f and Tsc1f/fCD11cCre mice (Figure 
4E and Figure S4A, B). Consistent with these observations, the numbers of Peyer’s patches and 
intestinal lymphoid structures were also similar between the two genotypes (Figure S4C). These 
results suggested that activation of mTORC1 signaling in CD11c cells might affect microbial 
homeostasis by altering their antigen presentation function. In support of this hypothesis, we 
observed higher mTORC1 activity in lamina propria CD11c cells of Tsc1f/fCD11cCre mice, which 
was associated with decreased capacity for antigen presentation in vitro (Figure S4D, E), as 
reported previously (Luo et al., 2017; Wang et al., 2013).   
 Secretory IgA directed against bacterial antigens has been proposed to shape intestinal 
microbial composition by multiple mechanisms, including inhibition of bacterial motility, 
reduction in bacterial fitness, exclusion of immune cells from the inner mucus layer, and creation 
of a specific mucosal niche to promote stable colonization by specific microbes (Cullender et al., 
2013; Donaldson et al., 2018; Gutzeit et al., 2014; Peterson et al., 2007). Because bacterial 
antigen presentation by lamina propria phagocytes, including CD11c cells, is critical for 
development of IgA secreting plasma cells, we hypothesized that deletion of Tsc1 in CD11c cells 
might alter the amount or specificity of secreted IgA against Lactobacillus strain Q1-7. We 
found that while the concentration of free IgA in stool was similar between Tsc1f/f and 
Tsc1f/fCD11cCre mice (Figure 4F), the bacterial bound IgA was significantly reduced in stool of 
4-week-old Tsc1f/fCD11cCre mice (Figure 4G). These observations led us to ask whether there 
was specific reduction in IgA directed against Lactobacillus strain Q1-7 in Tsc1f/fCD11cCre mice. 
To test this hypothesis, we purified free IgA from stool of Tsc1f/f and Tsc1f/fCD11cCre mice and 
performed an in vitro binding assay with cultured Lactobacillus strain Q1-7. We found that the 
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stool of Tsc1f/fCD11cCre mice contained less IgA that could specifically bind to Lactobacillus 
strain Q1-7 (Figure 4H), suggesting that reduced production of IgA directed against 
Lactobacillus strain Q1-7 might impair its stable colonization in the gastrointestinal tract of 
Tsc1f/fCD11cCre mice. 
DISCUSSION 
Previous studies have highlighted a role for inflammation and microbial dysbiosis in 
metabolic dysfunction associated with disease states of obesity and insulin resistance 
(Hotamisligil, 2017; Lee et al., 2018; Maruvada et al., 2017; Schroeder and Backhed, 2016; 
Sonnenburg and Backhed, 2016). However, the physiologic importance of these systems in 
maintenance of energy balance in healthy animals is less well understood. The data presented here 
provide an example of a transkingdom circuit involving CD11c cells and the gut microbe 
Lactobacillus strain Q1-7, which regulates food intake and body weight in lean animals. Utilization 
of a modified set of Koch’s postulates allowed us to identify this transkingdom circuit in 
Tsc1f/fCD11cCre mice. First, we found that the reduced food intake and body mass in 
Tsc1f/fCD11cCre mice was dependent on the host microbiome. Second, 16S rRNA sequencing of 
cohoused and microbiome chased mice led to the identification of L. johnsonii group as being 
selectively depleted in microbiome of Tsc1f/fCD11cCre mice. Third, Lactobacillus strain Q1-7 was 
selectively cultured from the microbiome of Tsc1f/f mice, and its reconstitution into 
Tsc1f/fCD11cCre mice increased food intake and body mass. And fourth, Tsc1f/fCD11cCre mice 
produced lower levels of Lactobacillus strain Q1-7-specific IgA, which is likely required for the 
stable colonization Lactobacillus strain Q1-7 in its microbial niche.  
A major challenge in the microbiome field is to identify specific microbial pathways and 
products that modulate host physiology and contribute to pathogenesis of disease (Maruvada et 
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al., 2017; Sonnenburg and Backhed, 2016). Although previous studies have implicated 
microbiome-derived short chain fatty acids, such as acetate, butyrate, and propionate, in 
regulation of food intake and weight gain (Frost et al., 2014; Koh et al., 2016), the levels of these 
and other metabolites were not significantly different between Tsc1f/f and Tsc1f/fCD11cCre 
(Figure 4D and S3H). In line with these observations, circulating levels of hormones that 
regulate satiety and meal size, such as leptin and GLP-1, failed to account for the effects L. 
johnsonii group on feeding behavior (Figure S3A-C). Together, these findings suggest that 
immune-microbiome interactions might employ distinct mechanisms to maintain metabolic 
homeostasis in healthy animals, an area that will be worthy of future investigations.  
Limitations of Study 
 There are some limitations of the present study. First, it is well appreciated that the host-
microbiome interactions are dynamic and dependent on the host environment. Thus, it remains 
unknown how environmental stimuli (diet, ambient temperature, and housing facility) might 
impact the microbial composition and metabolic phenotypes of Tsc1f/fCD11cCre mice. Second, 
CD11c is broadly expressed on dendritic cells, which reside at barrier surfaces and in lymphoid 
tissues. Thus, the precise location and mechanisms by which CD11c cells regulate production of 
IgA and abundance of Lactobacillus strain Q1-7 in the gut remain to be elucidated. Third, while 
we found that activation of nutrient sensing mTORC1 pathway in CD11c cells regulates food 
intake and body weight, the mechanisms by which nutrients or microbial products modulate 
mTORC1 signaling to alter functionality of CD11c cells, specifically those that reside in the 
lamina propria of the gut, will need to be investigated in the future. And fourth, it remains to be 
determined whether the transkingdom circuit identified here is representative of a broader 
mechanism for homeostatic regulation of food intake and body weight in mammals. 
 34 
ACKNOWLEDGMENTS 
We thank members of the Chawla laboratory and A. Loh for comments on the manuscript, A. 
Savage for assistance with SI and colon flow cytometry, and X. Cui for assistance with mouse 
husbandry. The authors’ work was supported by grants from NIH (DK094641, DK101064, 
P30DK098722) to A.C. and (C2273232, and HK122593) to P.J.T. Stipend support was provided 
by NIH NIDDK and UCSF MSTP (F31DK112669 and T32GM007618) to D.N.C. K.G. was 
supported by a postdoctoral fellowship from Hillblom Fellowship and CVRI T32 grant. Q.Y.A 
was supported by Agency for Science, Technology and Research, Singapore (National Science 
Scholarship). J.E.B. was supported by National Science and Engineering Research Council of 
Canada Postdoctoral Fellowship. The authors declare that they have no competing financial 
interests. 
 
AUTHOR CONTRIBUTION 
D.N.C., Q.Y.A., J.E.B., K.G., and J.C. designed and performed the main experiments. D.N.C., 
Q.Y.A., J.E.B., K.G., J.C., A.D.T., P.J.T., and A.C. conceived, discussed, interpreted the results, 
and wrote the paper.  
  
 35 
REFERENCES 
Belinson, H., Savage, A.K., Fadrosh, D., Kuo, Y.M., Lin, D., Valladares, R., Nusse, Y., 
Wynshaw-Boris, A., Lynch, S.V., Locksley, R.M., et al. (2016). Dual epithelial and immune cell 
function of Dvl1 regulates gut microbiota composition and intestinal homeostasis. JCI Insight 1. 
Cai, J., Zhang, L., Jones, R.A., Correll, J.B., Hatzakis, E., Smith, P.B., Gonzalez, F.J., and 
Patterson, A.D. (2016). Antioxidant Drug Tempol Promotes Functional Metabolic Changes in 
the Gut Microbiota. J Proteome Res 15, 563-571. 
Callahan, B.J., McMurdie, P.J., Rosen, M.J., Han, A.W., Johnson, A.J., and Holmes, S.P. (2016). 
DADA2: High-resolution sample inference from Illumina amplicon data. Nature methods 13, 
581-583. 
Cannon, B., and Nedergaard, J. (2011). Nonshivering thermogenesis and its adequate 
measurement in metabolic studies. The Journal of experimental biology 214, 242-253. 
Caporaso, J.G., Lauber, C.L., Walters, W.A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, 
S.M., Betley, J., Fraser, L., Bauer, M., et al. (2012). Ultra-high-throughput microbial community 
analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6, 1621-1624. 
Cullender, T.C., Chassaing, B., Janzon, A., Kumar, K., Muller, C.E., Werner, J.J., Angenent, 
L.T., Bell, M.E., Hay, A.G., Peterson, D.A., et al. (2013). Innate and adaptive immunity interact 
to quench microbiome flagellar motility in the gut. Cell Host Microbe 14, 571-581. 
De Vadder, F., Kovatcheva-Datchary, P., Zitoun, C., Duchampt, A., Backhed, F., and Mithieux, 
G. (2016). Microbiota-Produced Succinate Improves Glucose Homeostasis via Intestinal 
Gluconeogenesis. Cell Metab 24, 151-157. 
Donaldson, G.P., Ladinsky, M.S., Yu, K.B., Sanders, J.G., Yoo, B.B., Chou, W.C., Conner, 
M.E., Earl, A.M., Knight, R., Bjorkman, P.J., et al. (2018). Gut microbiota utilize 
immunoglobulin A for mucosal colonization. Science 360, 795-800. 
Dong, F.C., Zhang, L.L., Hao, F.H., Tang, H.R., and Wang, Y.L. (2013). Systemic Responses of 
Mice to Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis Using H-1 NMR 
Spectroscopy. Journal of Proteome Research 12, 2958-2966. 
Frost, G., Sleeth, M.L., Sahuri-Arisoylu, M., Lizarbe, B., Cerdan, S., Brody, L., Anastasovska, 
J., Ghourab, S., Hankir, M., Zhang, S., et al. (2014). The short-chain fatty acid acetate reduces 
appetite via a central homeostatic mechanism. Nature communications 5, 3611. 
Ganeshan, K., and Chawla, A. (2017). Warming the mouse to model human diseases. Nature 
reviews. Endocrinology 13, 458-465. 
Gonzalez, A., and Hall, M.N. (2017). Nutrient sensing and TOR signaling in yeast and 
mammals. The EMBO journal 36, 397-408. 
 36 
Gordon, C.J. (2017). The mouse thermoregulatory system: Its impact on translating biomedical 
data to humans. Physiol Behav 179, 55-66. 
Gutzeit, C., Magri, G., and Cerutti, A. (2014). Intestinal IgA production and its role in host-
microbe interaction. Immunological reviews 260, 76-85. 
Heiss, C.N., and Olofsson, L.E. (2018). Gut Microbiota-Dependent Modulation of Energy 
Metabolism. J Innate Immun 10, 163-171. 
Hotamisligil, G.S. (2017). Inflammation, metaflammation and immunometabolic disorders. 
Nature 542, 177-185. 
Ko, H.J., and Chang, S.Y. (2015). Regulation of intestinal immune system by dendritic cells. 
Immune Netw 15, 1-8. 
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., and Backhed, F. (2016). From Dietary Fiber 
to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell 165, 1332-1345. 
Lee, Y.S., Wollam, J., and Olefsky, J.M. (2018). An Integrated View of Immunometabolism. 
Cell 172, 22-40. 
Ley, R.E., Backhed, F., Turnbaugh, P., Lozupone, C.A., Knight, R.D., and Gordon, J.I. (2005). 
Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A 102, 11070-11075. 
Lumeng, C.N., Bodzin, J.L., and Saltiel, A.R. (2007). Obesity induces a phenotypic switch in 
adipose tissue macrophage polarization. J Clin Invest 117, 175-184. 
Luo, Y., Li, W., Yu, G., Yu, J., Han, L., Xue, T., Sun, Z., Chen, S., Fang, C., Zhao, C., et al. 
(2017). Tsc1 expression by dendritic cells is required to preserve T-cell homeostasis and 
response. Cell Death Dis 8, e2553. 
Man, K., Kutyavin, V.I., and Chawla, A. (2017). Tissue Immunometabolism: Development, 
Physiology, and Pathobiology. Cell Metab 25, 11-26. 
Maruvada, P., Leone, V., Kaplan, L.M., and Chang, E.B. (2017). The Human Microbiome and 
Obesity: Moving beyond Associations. Cell Host Microbe 22, 589-599. 
Moor, K., Fadlallah, J., Toska, A., Sterlin, D., Balmer, M.L., Macpherson, A.J., Gorochov, G., 
Larsen, M., and Slack, E. (2016). Analysis of bacterial-surface-specific antibodies in body fluids 
using bacterial flow cytometry. Nature protocols 11, 1531-1553. 
Morton, G.J., Meek, T.H., and Schwartz, M.W. (2014). Neurobiology of food intake in health 
and disease. Nat Rev Neurosci 15, 367-378. 
Nicholson, J.K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., and Pettersson, S. 
(2012). Host-gut microbiota metabolic interactions. Science 336, 1262-1267. 
 37 
Patsouris, D., Li, P.P., Thapar, D., Chapman, J., Olefsky, J.M., and Neels, J.G. (2008). Ablation 
of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell 
Metab 8, 301-309. 
Peterson, D.A., McNulty, N.P., Guruge, J.L., and Gordon, J.I. (2007). IgA response to symbiotic 
bacteria as a mediator of gut homeostasis. Cell Host Microbe 2, 328-339. 
Saxton, R.A., and Sabatini, D.M. (2017). mTOR Signaling in Growth, Metabolism, and Disease. 
Cell 168, 960-976. 
Schroeder, B.O., and Backhed, F. (2016). Signals from the gut microbiota to distant organs in 
physiology and disease. Nat Med 22, 1079-1089. 
Shi, X., Xiao, C., Wang, Y., and Tang, H. (2013). Gallic Acid Intake Induces Alterations to 
Systems Metabolism in Rats. Journal of Proteome Research 12, 991-1006. 
Silverman, J.D., Washburne, A.D., Mukherjee, S., and David, L.A. (2017). A phylogenetic 
transform enhances analysis of compositional microbiota data. Elife 6. 
Sonnenburg, J.L., and Backhed, F. (2016). Diet-microbiota interactions as moderators of human 
metabolism. Nature 535, 56-64. 
Stappenbeck, T.S., and Virgin, H.W. (2016). Accounting for reciprocal host-microbiome 
interactions in experimental science. Nature 534, 191-199. 
Tian, X.Y., Ganeshan, K., Hong, C., Nguyen, K.D., Qiu, Y., Kim, J., Tangirala, R.K., Tontonoz, 
P., and Chawla, A. (2016). Thermoneutral Housing Accelerates Metabolic Inflammation to 
Potentiate Atherosclerosis but Not Insulin Resistance. Cell Metab 23, 165-178. 
Tian, Y., Zhang, L.M., Wang, Y.L., and Tang, H.R. (2012). Age-Related Topographical 
Metabolic Signatures for the Rat Gastrointestinal Contents. Journal of Proteome Research 11, 
1397-1411. 
Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., Sogin, 
M.L., Jones, W.J., Roe, B.A., Affourtit, J.P., et al. (2009). A core gut microbiome in obese and 
lean twins. Nature 457, 480-484. 
Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., and Gordon, J.I. (2006). 
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 
1027-1031. 
Valdearcos, M., Douglass, J.D., Robblee, M.M., Dorfman, M.D., Stifler, D.R., Bennett, M.L., 
Gerritse, I., Fasnacht, R., Barres, B.A., Thaler, J.P., et al. (2017). Microglial Inflammatory 
Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates 
Obesity Susceptibility. Cell Metab 26, 185-197 e183. 
 38 
Wang, Q., Garrity, G.M., Tiedje, J.M., and Cole, J.R. (2007). Naive Bayesian classifier for rapid 
assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73, 
5261-5267. 
Wang, Y., Huang, G., Zeng, H., Yang, K., Lamb, R.F., and Chi, H. (2013). Tuberous sclerosis 1 
(Tsc1)-dependent metabolic checkpoint controls development of dendritic cells. Proc Natl Acad 
Sci U S A 110, E4894-4903. 
Waterson, M.J., and Horvath, T.L. (2015). Neuronal Regulation of Energy Homeostasis: Beyond 
the Hypothalamus and Feeding. Cell Metab 22, 962-970. 
Zheng, X., Qiu, Y., Zhong, W., Baxter, S., Su, M., Li, Q., Xie, G., Ore, B.M., Qiao, S., Spencer, 
M.D., et al. (2013). A targeted metabolomic protocol for short-chain fatty acids and branched-
chain amino acids. Metabolomics : Official journal of the Metabolomic Society 9, 818-827. 
 
 
 
  
 39 
FIGURE LEGENDS 
Figure 2.1. Activation of mTORC1 signaling in CD11c cells reduces body mass and food 
intake. 
(A) Body mass of Tsc1f/f and Tsc1f/fCD11cCre mice fed high fat diet (HFD) from age of 6 to 19 
weeks (n=6-8 per genotype; analyzed by two-way ANOVA).  (B, C) Glucose (B) and insulin (C) 
tolerance tests of Tsc1f/f and Tsc1f/fCD11cCre mice fed HFD (n=4-5 per genotype; analyzed by 
two-way ANOVA). (D) Body mass of Tsc1f/f and Tsc1f/fCD11cCre mice fed low-fat regular chow 
diet (n=5 per genotype; analyzed by two-way ANOVA). (E) Body composition analysis by 
DEXA of Tsc1f/f and Tsc1f/fCD11cCre mice fed low-fat regular chow diet (n=5 per genotype; 
analyzed by t-test). (F-H) Oxygen consumption (F), total activity (G), and food consumption 
over 24 hours in 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=7-9 per genotype; analyzed by 
t-test). (I) Assessment of energy harvest in 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice fed low-
fat regular chow diet using fecal bomb calorimetry (n=8-9 per genotype; analyzed by t-test). (J) 
Plasma concentrations of inflammatory cytokines in 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice 
fed low-fat regular chow diet (n=4 per genotype; analyzed by t-test). (K) Flow cytometric 
analysis of microglial populations in hypothalami of Tsc1f/f and Tsc1f/fCD11cCre mice fed low-fat 
regular chow diet. Total microglia (CD45midCX3CR1+); CD11c+ microglia 
(CD45midCX3CR1+CD11c+) and activated microglia (CD45midCX3CR1+CD68+), (n= 5 per 
genotype; analyzed by t-test). Dashed line designates that CD11c+ and activated microglia are 
subsets of total microglia. Data are presented as mean ± SEM. 
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Figure 2.1. Activation of mTORC1 signaling in CD11c cells reduces body mass and food intake.  
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Figure 2.2. Microbiome of Tsc1f/fCD11cCre mice reduces food intake and body mass. 
(A) Body mass of Tsc1f/f and Tsc1f/fCD11cCre mice on low-fat regular chow diet (n=5-15 per 
genotype; analyzed by t-test). (B-D) Body mass (B), body composition (C), and food 
consumption (D) in Tsc1f/f and Tsc1f/fCD11cCre mice fed low-fat regular chow diet and cohoused 
after weaning (n=4 per genotype; analyzed by two-way ANOVA (B) and t-test (C, D)). (E) 
PCoA using Bray Curtis dissimilarity for ordination of microbial communities of Tsc1f/f and 
Tsc1f/fCD11cCre mice fed low-fat regular chow diet that were cohoused or housed separately after 
weaning. Each data point represents a single mouse at 8 weeks of age, (n=7-8 per genotype; 
analyzed by ADONIS p=0.002, R2=0.472 comparing separately-housed Tsc1f/fCD11cCre mice to 
separately-housed Tsc1f/f mice and cohoused mice). (F) Phylogenetic tree of 16S rRNA sequence 
variants and internal nodes that are significantly different between Tsc1f/f and Tsc1f/f CD11cCre 
mice housed separately. Black circles denote significantly different nodes analyzed by Welch’s t 
test with multiple testing correction (FDR<0.1) with the size of the node representing absolute 
fold change. Colored tips denote significantly different sequence variants analyzed by DESeq2 
(FDR<0.1) with color representing fold change comparing Tsc1f/f CD11cCre mice to Tsc1f/f mice. 
Bacterial clades of interest are highlighted in grey. (G, H) Change in body mass (G) and food 
consumption (H) in C57BL/6J mice after 8 weeks of oral gavage of fecal contents from Tsc1f/f 
CD11cCre or Tsc1f/f mice (n=7 per genotype; analyzed by t-test). Data are presented as mean ± 
SEM. 
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Figure 2.3. Abundance of Lactobacillus johnsonii is reduced in microbiota of 
Tsc1f/fCD11cCre mice. 
(A) Schematic of Tsc1f/f mice being chased by microbiome of Tsc1f/f CD11cCre mice. (B, C) 
Change in body mass (B) and food intake (C) of Tsc1f/f mice during chase with microbiome of 
Tsc1f/f CD11cCre mice, (n=4-5, analyzed by 2-way ANOVA with Sidak’s multiple comparisons 
test (B) and t-test (C)). (D) Schematic of Tsc1f/f CD11cCre mice being chased by microbiome of 
Tsc1f/f mice. (E, F) Change in body mass (E) and food consumption (F) in Tsc1f/f CD11cCre mice 
during chase with microbiome of Tsc1f/f mice, (n=4-5, analyzed by 2-way ANOVA with Sidak’s 
multiple comparisons test (E) and t-test (F)). (G, H) Change in body mass (G) and food 
consumption (H) after 8 weeks of oral gavage of fecal contents from Tsc1f/f CD11cCre or Tsc1f/f 
mice into Tsc1f/f CD11cCre mice (n=8-9 per genotype; analyzed by t-test). (I) Volcano plot of 16S 
rRNA sequence variants that were different between Tsc1f/f CD11cCre moved to clean cage or 
chased with microbiome of Tsc1f/f mice. Red dots represent statistically significant sequence 
variants (analyzed by linear mixed effects model; log2 fold change>1 and FDR<0.1). Full 
taxonomic annotations for the three significant sequence variants are: Lactobacillus 
johnsonii/crispatus/gasseri/helveticus/hominis/iatae/johnsonii/kefiranofaciens/prophage/taiwanes
is (species), Rikenellaceae RC9 gut group (genus), and Muribaculaceae (family). (J) Schematic 
of the flowchart used to identify L. johnsonii as being less abundant in microbiome of Tsc1f/f 
CD11cCre mice. (K) Changes in relative abundance of L. johnsonii in stool of Tsc1f/f CD11cCre 
mice during chase with microbiome of Tsc1f/f mice (as in E, F). The dashed lines denote the 
period of microbiome chase experiment, (n = 2 per chase group; error bars represent range; 
analyzed by linear mixed effects model FDR<0.1). Data are presented as mean ± SEM. 
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Figure 2.3. Abundance of Lactobacillus johnsonii is reduced in microbiota of Tsc1f/fCD11cCre 
mice. 
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Figure 2.4. Reconstitution of Lactobacillus strain Q1-7 increases food intake and body mass 
in Tsc1f/fCD11cCre mice. 
(A-C) Change in body mass (A), food intake (B), and qRT-PCR analysis for relative abundance 
of Lactobacillus relative in feces (C) of Tsc1f/f CD11cCre mice orally gavaged with fecal contents 
of Tsc1f/f CD11cCre mice that were supplemented with vehicle or Lactobacillus strain Q1-7 
(5x109 cfu) for 6 weeks, (n=6-7 per genotype; analyzed by t-test). (D) Quantification of cecal, 
fecal, and plasma short chain fatty acids by GC-MS (n=7 per genotype; analyzed by Mann-
Whitney). (E) Quantification by flow cytometry of B cells and IgA+ B cells in proximal small 
intestines (SI) and colons of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=3-4 per genotype; 
analyzed by t-test). (F, G) Quantification of free IgA (F) and bacterial bound IgA (G) in stool of 
4-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=9-11 per genotype; analyzed by t-test). (H) 
Quantification of free IgA specific for Lactobacillus strain Q1-7 in stool of 4-week-old Tsc1f/f 
and Tsc1f/fCD11cCre mice (n=9-11 per genotype; analyzed by t-test). Data are presented as mean 
± SEM. 
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Figure 2.4. Reconstitution of Lactobacillus strain Q1-7 increases food intake and body mass in 
Tsc1f/fCD11cCre mice. 
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METHODS 
Animal studies 
All animal studies were conducted under an approved Institutional Animal Care and Use 
Committee (IACUC) protocol at University of California, San Francisco (UCSF). Mice were 
housed at 30°C after weaning (unless otherwise indicated) in Darwin or Power Scientific 
environmental chambers under a 12-hr light:dark cycle. Tsc1f/f and CD11cCre mice were purchased 
from Jackson Laboratories, backcrossed onto C57BL/6J background (Nnt null) for 10 generations, 
and used to generate Tsc1f/f CD11cCre mice. Littermate Tsc1f/f and Tsc1f/fCD11cCre mice were 
either separated at weaning or continually cohoused for the duration of the experiments. Mice were 
fed normal chow diet (5053, Pico labs) or high fat diet (D12492i, Research Diets). For microbiome 
chase experiments, mice were moved to a clean cage or a dirty cage every day for duration of the 
experiment. 
Food intake 
Successive food consumption was calculated using the formula: [(Food mass) on Day(N) – (Food 
mass) on Day(N+1)], and values were adjusted for the number of mice per cage. The same number 
of mice per cage were compared between experimental groups to minimize the impact of housing 
density on food consumption.  
Energy expenditure and body composition analysis 
Body composition (fat and lean mass) analysis were performed on anesthetized mice using Dual-
energy X-ray absorptiometry (DEXA). For measurement of energy expenditure, food intake, and 
locomotor activity, mice were placed in CLAMS (Columbus Instruments) cages that housed in an 
environmental chamber set at 30°C. After acclimatization for one day, data on oxygen 
consumption, locomotor activity, and food intake was collected every 22 minutes.  
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Glucose and insulin tolerance tests 
For glucose and insulin tolerance tests, mice were intraperitoneally injected with glucose (1.5g/kg 
of body weight) after 14h fast or insulin (1U/kg of body weight) after 6h fast, and blood glucose 
was measured at regular intervals using tail blood. 
Bomb calorimetry  
Fecal samples were collected and lyophilized to obtain dried mass. Approximately, 200 mg of 
dried stool was pressed into a pellet using a pellet press. Gross energy content was measured using 
a semimicro oxygen bomb in an isoperibol calorimeter. The calorimeter energy equivalent factor 
was determined using benzoic acid standards. Data are presented as a percentage of energy 
consumed by each genotype.  
Quantitative RT-PCR  
As per manufacturer’s protocols, fecal DNA or tissue RNA was extracted using Bioline Fecal 
DNA or RNA kits, respectively. RNA was reverse transcribed into cDNA using qScript cDNA 
Supermix (Quanta), and quantitative PCR was performed on CFX384 real-time PCR detection 
system (Bio-rad). Relative expression levels were determined using the ΔΔCt method with 36B4 
or GAPDH serving as an internal reference. Lactobacillus expression was normalized to stool 
weight. Primers used are listed in Supplemental Table 1. 
Histology 
Brown fat, small intestines, and colons were fixed in 10% formalin for 4-24 hours and stored at 
4°C in 20% sucrose in PBS. Paraffin embedded tissues were sectioned at 5 µm, stained with 
hematoxylin and eosin, and imaged using an Olympus BX41 equipped with a Digital Sight DS-
Fi1 camera (Nikon). 
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Immunoblotting 
Snap-frozen tissues were homogenized in modified RIPA buffer (420 mM NaCl, 1% NP- 40, 0.1% 
SDS, 0.5% sodium deoxycholate, 50 mM Tris pH 7.5, and protease inhibitor cocktail) using a 
TissueLyser II (Qiagen). Total protein was separated by SDS-PAGE, transferred to nitrocellulose 
membranes, and probed with primary anti-UCP1 and secondary anti-IgG HRP antibodies. 
Immunoblotted proteins were detected using SuperSignal West Pico Chemiluminescent Substrate 
(Thermo Scientific).  
Bone marrow dendritic cells (BMDCs) and antigen presentation assay 
Bone marrow cells were flushed from femurs and tibias of Tsc1f/f and Tsc1f/fCD11cCre mice, and 
cultured in RPMI 1640 supplemented with 10% FBS, 10 mM HEPES pH 7.0, 100 U/ml penicillin, 
1000 U/ml streptomycin, 20 mM l-glutamine, and 20 ng/ml GM-CSF. On day 3 of culture, half 
the medium was replaced with fresh medium. On day 7, BMDCs were used for experiments or 
flow cytometric analysis. For in vitro antigen presentation assay, BMDCs from Tsc1f/f and 
Tsc1f/fCD11cCre mice were pulsed with OVA 323-339 (10µg/ml) or 257-264 (25µg/ml) for 4 
hours. CD4 and CD8 T cells were purified from the spleens of OT-II/OT-I transgenic mice using 
MACS kits. T cells were pulsed with CFSE (2 µM) for 5 min at 37 °C and then washed twice with 
PBS. Purified T cells (1x105) were then incubated with OVA BMDCs (1x105) for 3 days. Cells 
were washed, and stained with antibodies against CD4, CD8 and CD69 (marker of T cell 
activation). Data was acquired using FACSVerse (Becton Dickinson) and analyzed using FlowJo 
software. 
Flow cytometry and serum cytokines 
Small intestine and colon flow cytometric analyses were performed as described previously 
(Belinson et al., 2016). Briefly, proximal and distal intestine and colon were dissected. Colon 
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length was measured and numbers of Peyer’s Patches (PPs) and intestinal lymphoid structures 
(ILSs) were removed and counted. The gut tissue was then shaken in three times in 20 ml cold 
PBS, washed twice for 20 minutes at 37°C in 20 ml of Ca2+/Mg2+-free HBSS containing 5 mM 
DTT, 5 mM EDTA, 10 mM HEPES, and 2% FCS, followed by washing in 20 ml of Ca2+/Mg2+-
replete HBSS containing 10 mM HEPES with 2% FCS. Tissues were then digested for 30 
minutes at 37°C in 5 ml of Ca2+/Mg2+-replete HBSS containing 10 mM HEPES, 2% FCS, 30 
µg/ml DNase, 0.1 Wünsch/ml LibTM (Roche), homogenized in C tubes using a gentleMACS 
tissue dissociator (Miltenyi), and then passed through a 100-µm filter. The filtrate was separated 
in a 40%/90% Percoll gradient and stained for innate and adaptive immune cells. Data was 
acquired using FACSVerse (Becton Dickinson) and analyzed using FlowJo software. Plasma 
cytokine levels were measured by cytometric bead array-mouse inflammation kit (BD 
Biosciences, San Jose, CA) as per manufacturer’s instructions.  
Intestinal macromolecular permeability assay 
Intestinal macromolecular permeability assay was performed in mice after a 5h fast. Mice were 
orally gavaged with 400µg of fluorescein isothiocyanate (FITC)-dextran (4kDA/g body weight), 
and 5 hours later, FITC-dextran was detected in plasma samples using flow cytometry. 
Measurement of GLP-1 and leptin 
For measurement of active GLP-1, mice were fasted for 6 hours and given 2g/kg glucose by oral 
gavage. 15 mins later, mice were bled retro-orbitally using ice-cooled heparinized capillary tubes. 
DPP4 inhibitor was immediately added at 10µL per ml of blood. Samples were centrifuged at 
1,000g for 10 mins and GLP-1 levels measured according to manufacturer’s protocol. For 
measurement of leptin, mice were bled retro-orbitally at 7am, blood was centrifuged at 8,000g for 
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8 mins. Resulting plasma was diluted 5x with PBS and leptin levels measured according to 
manufacturer’s instructions. 
Short chain fatty acids quantitation by GC-MS 
Short chain fatty acids were quantified with a previously described propyl esterification method using 
Agilent 7890A gas chromatograph coupled with Agilent 5975 mass spectrometer (Agilent Technologies 
Santa Clara, CA). Briefly, 50 mg cecal/fecal samples or 300 µL of serum collected were mixed with 1 mL 
of 5 mM NaOH containing 10 µg/mL internal standard hexanoic acid-6,6,6-d3 (C/D/N Isotopes Inc, 
Pointe-Claire, Quebec, Canada), homogenized (Bertin Technologies, Rockville, MD) at 6500 rpm for 1 
minute until thoroughly homogenized. 1.0 mm diameter Zirconia/Silica beads (BioSpec, Bartlesville, OK) 
were added for through homogenization (Zheng et al., 2013). The homogenized samples then were 
centrifuged (Eppendorf, Hamburg, Germany) at 13,200 x g, 4 °C, 20 minutes. The supernatant was taken 
and mixed with an aliquot of 500 µL of 1-propanol/pyridine (v/v=3:2) solvent. 100 µL of derivatization 
reagent propyl chloroformate was added slowly following a brief vortex for 1 minute. Samples were 
derivatized in an incubator (Thermo Scientific, Marietta OH) at 60 °C for an hour. The derivatized 
samples were extracted with a two-step hexane extraction (300 µL + 200 µL). A total 500 µL of upper 
layer was transferred to a glass auto sampler vials for GC-MS analysis. A calibration curve with pure 
standards was drafted for quantitation as described (Cai et al., 2016).   
1H NMR-based global metabolomics 
Cecal content, feces and serum metabolites were extracted as previously described (Cai et al., 2016; Shi et 
al., 2013). 1H NMR spectra were recorded at 298 K on a Bruker Avance III 600 MHz spectrometer 
equipped with an inverse cryogenic probe (Bruker Biospin, Germany). NMR spectra of cecal and fecal 
samples were acquired using the first increment of NOESY pulse sequence with presaturation (Bruker 1D 
noesygppr1d pulse sequence). The serum spectra were acquired with a Carr-Purcell-Meiboom-Gill pulse 
sequence [recycle delay-90°-(τ-180°-τ)n-acquisition]. Quality of all spectra were improved by phase 
adjustment, baseline correction and calibration using Topspin 3.0 (Bruker Biospin, Germany). The 
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spectral region δ 0.50-9.50 was integrated into bins with equal width of 0.004 ppm (2.4 HZ) using AMIX 
package (V3.8, Bruker Biospin) for relative concentration analysis. The metabolites were assigned based 
on published results (Cai et al., 2016; Dong et al., 2013; Tian et al., 2012). 
IgA Binding Assay 
IgA was isolated by homogenizing stool in PBS containing protease inhibitor (0.1 mg/µl) 
followed by centrifugation at 400g. Supernatant was collected by filtration through a 70 µm 
strainer followed by centrifugation at 8000g to pellet the bacteria. IgA concentration in the 
supernatant was quantified by Mouse IgA ELISA (Bethyl Laboratories). For quantifying IgA 
bound bacteria, bacterial pellets were resuspended in PBS supplemented with 5% goat serum and 
SYTO BC (ThermoFisher Technologies) followed by incubation for 15 minutes on ice. Anti-
IgA-Alexa Fluor 647 (Southern Biotech) was added for 20 minutes on ice. Samples were washed 
and resuspended in PBS with DAPI (ThermoFisher Technologies) for flow cytometric analysis.  
Data was acquired on FACSVerse (Becton Dickinson) using a low FSC and SSC threshold (in 
log scale) to allow for bacterial detection and analyzed using FlowJo software. Samples were 
gated as FSC+SSC+SYTOBC+DAPI- and assessed for IgA staining.  IgA-Lactobacillus strain 
Q1-7 binding assay was performed as previously described (Moor et al., 2016). Briefly, 25µl of 
5x106cfu/ml Lactobacillus strain Q1-7 was incubated with 25µl of free IgA (3µg/ml), which was 
obtained from stool of Tsc1f/f and Tsc1f/fCD11cCre mice, in a V-bottom-96 well plate overnight at 
4°C. The incubated samples were washed in bacterial flow cytometry buffer (PBS with 2% BSA 
(wt/vol) and 0.02% sodium azide (wt/vol) by centrifugation at 4,000g for 10min at 4°C. The 
samples were then stained with 50µl of 10µg/ml IgA-FITC antibody (BD Biosciences) at RT for 
15min, washed, and bacterial pellets were resuspended in 300µl bacterial flow cytometry buffer. 
Data was acquired using FACSVerse (Becton Dickinson) with a low FSC and SSC threshold to 
 53 
allow bacterial detection and analyzed using FlowJo software. FSC and SSC were set to log scale 
and gated bacteria were assessed for IgA binding. 
16S rRNA Gene Sequencing and Analysis 
Mouse fecal pellets were homogenized with bead beating for 5 min (Mini-Beadbeater-96, 
BioSpec) using beads of mixed size and material (Lysing Matrix E 2mL Tube, MP Biomedicals) 
in the digestion solution and lysis buffer of a Wizard SV 96 Genome DNA kit (Promega). The 
samples were then centrifuged for 10 min at 16,000g and the supernatant was transferred to the 
binding plate. The DNA was then purified according to the manufacturer's instructions. 16S 
rRNA gene PCR was carried out using GoLay-barcoded 515F/806R primers (Caporaso et al., 
2012). 2µL of DNA was combined with 25 µL of AmpliTaq Gold 360 Master Mix (Fisher 
Scientific), 5 µL of primers (2µM each GoLay-barcoded 515/806R), and 18µL H2O. 
Amplification was as follows: 10 min 95˚C, 30x (30s 95˚C, 30s 50˚C, 30s 72˚C), and 7 min 
72˚C. Amplicons were quantified with PicoGreen (Quant-It dsDNA; Life Technologies) and 
pooled at equimolar concentrations. Aliquots of the pools were then column (MinElute PCR 
Purification Kit; Qiagen) and gel purified (QIAquick Gel Extraction Kit; Qiagen). Libraries were 
then quantified (KAPA Library Quantifcation Kit; Illumina) and sequenced with a 600 cycle 
MiSeq Reagent Kit (251x151; Illumina) with 20-50% PhiX. Raw data was deposited in the 
NCBI Sequence read archive under SRP154475. Reads were demultiplexed using QIIME v1.9.1 
(split_libraries_fastq.py) before denoising and processing with DADA2 v1.1.5 under MRO 
v3.2.5 (Callahan et al., 2016). Taxonomy was assigned using the DADA2 implementation of the 
RDP classifier using the DADA2 formatted training sets for SILVA123 
(benjjneb.github.io/dada2/assign.html) (Wang et al., 2007). A phylogenetic tree was constructed 
using MUSCLE v3.8.31 using the FastTree algorithm with midpoint rooting. Sequence variants 
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were filtered such that they were present in more than one sample with at least a total of 10 
reads. Diversity metrics were generated using Vegan v2.5-2 with principal coordinate analysis 
(PCoA) carried out with Ape v5.1. The Wald test in DESeq2 package (v1.20) was used to 
analyze differential abundances on count data. PhILR transformation was carried out with the 
package philr v1.6 as described and analyzed using t test with multiple testing correction across 
features/nodes tested (Silverman et al., 2017). For the separated housing experiments, significant 
nodes and sequence variants were visualized on a phylogenetic tree using the ggtree package 
v1.12. For the microbiome chase experiment, variance stabilizing transformation (DESeq2 
package v1.20) was applied on count data, and time-course analysis was carried out using linear 
mixed effect models (lmerTest v3.0-1) with mouse as a random effect to account for repeated 
sampling across time using the with a 0.05 Benjamini-Hochberg false discovery rate cutoff for 
significance. 
Isolation and identification of Lactobacillus species 
Lactobacillus species were isolated from stool of Tsc1f/f mice by plating diluted stool on MRS 
agar with and without vancomycin (50µg/mL) followed by incubation at 37°C for 24 hours under 
anaerobic conditions using BBLTM GasPak 100TM EZ gas generating container (Becton 
Dickinson). 11 colonies were randomly selected, and 16S rRNA DNA was PCR amplified using 
8F and 1543R universal 16S rRNA primers. PCR products were sequenced (Sanger sequencing) 
and Lactobacillus species were identified using BLAST against the NCBI nonredundant 
nucleotide and 16S rRNA databases. Lactobacillus isolates were stored in MRS media with 20% 
glycerol at –80°C. For oral gavage, Lactobacillus strain Q1-7 was grown in MRS broth and 
concentrated by centrifugation at 8,000g for 5min. Mice were orally gavaged with 5x109 cfu 
Lactobacillus strain Q1-7 resuspended in 100 µL of saline six days a week.  
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Fecal microbiota transplantation  
Antibiotics (vancomycin hydrocholoride (5 mg/ml), metronidazole (10 mg/ml), ampicillin 
(10mg/ml), and neomycin trisulfate salt hydrate (10 mg/ml)) were administered to mice in drinking 
water for 24 hours. Fresh feces were collected from three to four mice in PBS (supplemented with 
0.05% cysteine, 1µg/ml vitamin K, 15% glycerol, 5 µg/ml hemin), gently homogenized, pooled, 
and passed through a 100-µm cell strainer. The suspension was administered by oral gavage six 
days a week in mice treated with antibiotics.  
Statistical analysis 
Data were analyzed using Prism (GraphPad) and are presented as mean±SEM. Statistical 
significance was determined using the unpaired two-tailed Student’s t test for single variables and 
two-way ANOVA for two variables. A p-value of <0.05 was considered to be statistically 
significant. 
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Supplemental Figures 
Figure S2.1. Phenotypic and metabolic characterization of Tsc1f/f and Tsc1f/fCD11cCre mice. 
Related to Figure 2.1. 
(A) qRT-PCR analysis for Tsc1 and Tsc2 mRNAs in day 7 bone marrow-derived dendritic cells 
(n=6 per genotype; analyzed by t-test). (B, C) Assessment of mTORC1 signaling in day 7 
CD11c+ bone marrow-derived dendritic cells from Tsc1f/f and Tsc1f/fCD11cCre mice (n=4-7 per 
genotype; analyzed by t-test). pS6 median fluorescence intensity (MFI) (B) and pS6+ cells (C). 
(D) Body length of Tsc1f/f and Tsc1f/fCD11cCre mice at 4 and 16 weeks of age. (n=4-5 per 
genotype; analyzed by t-test). (E) Oxygen consumption per mouse over 24 hours in 8-week-old 
Tsc1f/f and Tsc1f/fCD11cCre mice (n=7-9 per genotype; analyzed by t-test). (F) qRT-PCR analysis 
of thermogenic genes in BAT tissue of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=7 per 
genotype; analyzed by t-test). (G) Immunoblot for UCP1 protein for mice on HFD housed at 
30°C (n=3-4 per genotype). (H) qRT-PCR analysis for Pomc and Agrp mRNAs in hypothalamus 
of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=4 per genotype; analyzed by t-test). Data are 
presented as mean ± SEM. 
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Figure S2.1. Phenotypic and metabolic characterization of Tsc1f/f and Tsc1f/fCD11cCre mice. 
Related to Figure 2.1. 
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Figure S2.2. Analysis of small intestines and colon of Tsc1f/f and Tsc1f/fCD11cCre mice. 
Related to Figure 2.1. 
(A) Hematoxylin and eosin staining of representative images of small intestines from Tsc1f/f and 
Tsc1f/fCD11cCre mice. (B) Quantification of plasma levels of FITC-Dextran levels 6 hours after 
oral gavage to Tsc1f/f and Tsc1f/fCD11cCre mice (n=7-8 per genotype; analyzed by t-test). (C-E) 
qRT-PCR analysis for tight junction mRNAs in intestines (C), cytokines in mesenteric lymph 
nodes (mLN) and Peyer’s Patches (D), and gut barrier and antimicrobial mRNAs in intestines 
(E) of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=3-4 per genotype; analyzed by t-test). (F) 
Spleen mass of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=7 per genotype; analyzed by t-
test). Data are presented as mean ± SEM. 
 
  
 59 
Figure S2.2. Analysis of small intestines and colon of Tsc1f/f and Tsc1f/fCD11cCre mice. Related 
to Figure 2.1. 
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Figure S2.3. Microbiome analysis of Tsc1f/f and Tsc1f/fCD11cCre mice. Related to Figures 2.2 
and 2.3.  
(A-C) Plasma levels of leptin (A), and GLP-1 in separately housed (B) and cohoused (C) Tsc1f/f 
and Tsc1f/fCD11cCre mice (n=8 per genotype for leptin and n=4-8 per genotype for GLP-1). 
(D) Principal Coordinates Analysis (PCoA) of Bray Curtis dissimilarity for ordination of microbial 
communities of Tsc1f/f and Tsc1f/fCD11cCre mice cohoused or housed separately after weaning. 
Each data point represents a single mouse at 8 weeks of age (n=15-19 per genotype; analyzed by 
ADONIS; p=0.0001, R2=0.255 comparing separately-housed Tsc1f/fCD11cCre mice to separately-
housed Tsc1f/f mice and co-housed mice). (E) Schematic outline for isolation of Lactobacillus 
strain Q1-7 from stool of Tsc1f/f mice. (F, G) Changes in abundance of Rikenellaceae RC9 group 
(F) and Muribaculaceae group (G) during microbiome chase of Tsc1f/fCD11cCre mice (n = 2 per 
chase group; error bars represent range; analyzed by linear mixed effects model FDR<0.1). The 
dashed lines denote the duration of the microbiome chase. (H) Quantification of cecal, fecal, and 
plasma metabolites by NMR (n=7 per genotype; analyzed by Mann-Whitney), *p < 0.05. 
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Figure S2.3. Microbiome analysis of Tsc1f/f and Tsc1f/fCD11cCre mice. Related to Figures 2.2 
and 2.3.  
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Figure S2.4. Flow cytometric analysis of intestinal immune cells in lamina propria of of 
Tsc1f/f and Tsc1f/fCD11cCre mice. Related to Figure 2.4.  
(A, B) Quantification by flow cytometry of macrophage and dendritic cell subsets in colon (A) 
and small intestines (B) of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=3-9 per genotype; 
analyzed by t-test).  (C) Quantification of Peyer’s Patches (PPs) and intestinal lymphoid 
structures (ILS) in distal small intestines of 8-week-old Tsc1f/f and Tsc1f/fCD11cCre mice (n=9 
per genotype; analyzed by t-test). (D) Assessment of mTORC1 signaling by intracellular staining 
for pS6 in CD45+CD11c+ cells isolated from intestinal lamina propria of Tsc1f/f and 
Tsc1f/fCD11cCre mice (n=4-6 per genotype; analyzed by t-test). (E) Percent CD4 and CD8 active 
(CD69+) and proliferated T cells. (n=3 per genotype; analyzed by t-test).  Data are presented as 
mean ± SEM. 
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Figure S2.4. Flow cytometric analysis of intestinal immune cells in lamina propria of of Tsc1f/f 
and Tsc1f/fCD11cCre mice. Related to Figure 2.4.  
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CHAPTER 3. 
The role of housing temperature and diet on  Tsc1f/fCD11cCre mice. 
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ABSTRACT 
Thermoneutral housing has been implicated as playing an important role in mouse physiology. 
However, it is not known what the effect of housing temperature is on insulin sensitivity and 
weight gain. In addition it is unknown what the effect of housing temperature is on microbial 
transfer of phenotypes. Here we show that in Tsc1f/fCD11cCre mice, thermoneutral housing 
uncouples the reduced weight phenotype from insulin sensitivity when mice are exposed to a 
high-fat diet. In normal-chow diet mice, room temperature uncouples the reduced weight 
phenotype from sufficiency of the Tsc1f/fCD11cCre microbiome to transfer this phenotype. 
Together our findings reveal that the housing temperature of mice is a crucial factor that 
determines different aspects of metabolic phenotypes, specially weight gain, insulin sensitivity 
and microbial transfer of phenotypes.  
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INTRODUCTION 
 The effect of housing temperature on metabolic and microbial phenotypes in mice is 
understudied. The majority of mouse studies are performed at room-temperature (22°C), 
however mice are significantly cold-stressed at this temperature. Thermoneutrality is defined as 
the temperature for which an organism expends the least amount of energy for warmth or cooling 
- this thermoneutral zone is 30°C for mice (Tian et al., 2016). C57BL/6 mice housed at 22°C 
exhibit a two fold increase in energy expenditure and heart rate in order to stay warm compared 
to mice housed at thermoneutrality (30°C ) (Swoap et al., 2008). With such immense differences 
in energy expenditure between mice housed at room temperature or thermoneutrality, we asked 
what the consequence of temperature would be  on weight gain, insulin sensitivity and the 
microbiome. 
 Mice on a high-fat diet develop insulin insensitivity due to an increase in low-grade, 
chronic inflammation. In particular, inflammatory macrophages are recruited to adipose tissue 
and lead to the progression of insulin resistance by increased circulation of pro-inflammatory 
cytokines such as TNFα, MCP-1 and IL-6 (Odegaard and Chawla, 2013; Osborn and Olefsky, 
2012). We therefore hypothesized that housing temperature would have an effect on high-fat diet 
induced weight gain and insulin sensitivity in Tsc1f/f mice and Tsc1f/fCD11cCre mice.   
 Another aspect of our phenotype as described in Chapter 2 is the role of the microbiome 
in protection from weight gain in Tsc1f/fCD11cCre mice. Although to the best of our knowledge 
no direct comparison has been done between the microbiomes of thermoneutral (30°C) and 
room-temperature (22°C) housed mice, Worthmann et al. compared the microbiomes between 
(30°C)  and (6°C) housed mice. From their work we do know that the gut microbiome is 
significantly altered at the species level between these two temperatures, with lower richness and 
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a decreased Shannon index occurring at cold exposure (Worthmann et al., 2017).  We therefore 
hypothesized that the housing temperature of the host has an impact on the microbiome and its 
sufficiency to transfer a phenotype between mice.  
Here we tested the hypothesis that altering the housing temperature of mice was sufficient to 
affect metabolic and microbiome phenotypes. We found that when mice were on a high-fat diet 
thermoneutrality was sufficient to uncouple protection from weight gain with protection from 
insulin insensitivity. In addition, when mice were on a low-fat normal chow diet, room 
temperature was sufficient to uncouple protection from weight gain from sufficiency of the 
Tsc1f/fCD11cCre  microbiome to transfer the phenotype to C57BL/6 mice. Our findings suggest 
that housing temperature of mice has an immense impact on both metabolic and microbiome 
phenotypes.  
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RESULTS 
Activation of mTORC1 signaling in CD11c cells reduces body mass and food intake in 
high-fat diet fed mice at thermoneutrality.  
 We first asked if placing Tsc1f/fCD11cCre mice on a high-fat diet (protein 20%, fat 60%, 
carbohydrates 20%) while housed at thermoneutrality would recapitulate the phenotype we 
observed on a low-fat normal chow diet (protein 24.517%, fat 13.134%, carbohydrates 
62.349%). We found that even when placed on a high-fat diet,  Tsc1f/fCD11cCre mice still 
weighed less than Tsc1f/f mice (Figure 3.1A). From Dual-Energy X-ray Absorptiometry (DEXA) 
we found that these differences were due to decreased fat mass in Tsc1f/fCD11cCre mice (Figure 
3.1B). We next asked if these Tsc1f/fCD11cCre mice weighed less due to a reduction in food 
consumption.  To do this we measured metabolic parameters for 48 hours in a Comprehensive 
Lab Animal Monitoring System (CLAMS) chamber. We found that Tsc1f/fCD11cCre mice 
consumed less food than Tsc1f/f mice (Figure 3.1C), whereas the other metabolic parameters of 
oxygen consumption, RER and physical activity (Figure 3.1D-F) were not significantly different.  
 
Thermoneutrality uncouples reduced weight gain from insulin intolerance Tsc1f/fCD11cCre 
mice on a high-fat diet. 
 Housing temperature has been shown to have a large effect on numerous metabolic 
parameters in mice . We next wanted to ask if and how temperature would affect the metabolic 
phenotypes of Tsc1f/fCD11cCre mice on a high-fat diet. We first established that Tsc1f/fCD11cCre 
mice still weighed less compared to Tsc1f/f mice when housed at 22°C and on a high-fat diet 
(Figure 3.2A). One characteristic of mice on a high-fat diet is diet induced insulin insensitivity. 
We therefore asked what the effect of temperature on insulin insensitivity was in Tsc1f/fCD11cCre 
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mice. Glucose and insulin tolerance tests revealed that Tsc1f/fCD11cCre mice were protected from 
high-fat diet induced insulin insensitivity at 30°C (Figure 3.2C and E) but not at 22°C (Figure 
3.2C and E). As fasting time and glucose dosage can affect glucose-tolerance test outcomes, we 
asked if altering either of these would result in insulin sensitivity differences at 30°C . Even a 
shorter fasting time (6 hours versus overnight) and a higher dosage of glucose (1g/kg versus 
1.5g/kg) did not result in insulin sensitivity differences between Tsc1f/fCD11cCre and Tsc1f/f mice 
housed at 30°C (Figure S3.1A-B).  
 
The Tsc1f/fCD11cCre microbiome is sufficient to confer a reduced weight gain phenotype to 
C57BL/6 mice only at thermoneutrality, not at room temperature.  
 We next examined the effect of temperature on the microbiome of Tsc1f/fCD11cCre mice. 
The reduced weight phenotype in Tsc1f/fCD11cCre mice relative to Tsc1f/f mice holds 
independent of housing temperature (Figure 3.2F). We then asked if housing temperature 
affected the sufficiency of the Tsc1f/fCD11cCre  microbiome to transfer the reduced weight 
phenotype to C57BL/6 mice . We tested this by gavaging antibiotic treated C57BL/6 mice with 
stool from Tsc1f/fCD11cCre mice or Tsc1f/f mice. We found that the microbiome in stool from 
Tsc1f/fCD11cCre mice  was sufficient to cause a reduced weight phenotype only in C57BL/6 mice  
housed at 30°C (Figure 3.2G) but not in C57BL/6 mice  housed at 22°C (Figure 3.2H).  
 In summary this chapter elucidates how temperature and diet affect metabolic and 
microbial phenotypes of Tsc1f/fCD11cCre mice. When mice are on a high-fat diet, 
thermoneutrality uncouples insulin sensitivity from the reduced weight gain phenotype. When 
mice are on a low-fat diet, room temperature uncouples the microbiome sufficiency from weight 
phenotype (Figure 3.3).  
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DISCUSSION 
This chapter has established the role of housing temperature on metabolic and microbiome 
phenotypes. Thermoneutrality uncouples reduced weight gain from insulin sensitivity in mice on 
a high-fat diet. Immune cell infiltrates in epididymal fat causes insulin resistance in high-fat diet 
fed mice (Shoelson et al., 2006). Future work will therefore examine differences in epididymal 
fat pad immune cell populations. This will be done by flow cytometric analysis of CD11c+ cell, 
T and B-cell subsets.  
 Room temperature uncouples protection from weight gain with microbiome sufficiency 
to transfer a phenotype. This suggests that the microbiomes of mice housed at 30°C and 22°C are 
different and that different mechanisms are resulting in the same phenotype depending on 
housing temperature. Tsc1f/fCD11cCre mice  are protected from weight gain at both 30°C and 
22°C  but the underlying microbiome changes that result in this could be different. 16S 
sequencing of stool from both Tsc1f/f mice and Tsc1f/fCD11cCre mice will be performed.  To 
further examine the effect of temperature on transfer of phenotype through the microbiome 
future work will treat C57BL/6 mice housed at 30°C and 22°C with stool from Tsc1f/fCD11cCre 
mice housed at 30°C and 22°C  (Figure 3.4).  If C57BL/6 mice housed at 30°C  weigh less when 
given stool from 22°C  housed Tsc1f/fCD11cCre mice then this indicates that  thermoneutrality 
housed C57BL/6 mice are “universal acceptors” regardless of donor temperature. If however the 
weight phenotype does not transfer then this indicates that a match between donor and recipient 
housing temperature is needed. If C57BL/6 mice housed at 22°C  weigh less when given stool 
from 22°C  housed Tsc1f/fCD11cCre mice this this indicates that a match between donor and 
recipient housing temperature is needed. If however there is no weight difference then this 
indicates that the mechanism of the  microbiome in this phenotype is temperature specific. That 
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is,  the microbiome is sufficient to cause weight changes between  Tsc1f/f and Tsc1f/fCD11cCre 
mice only at thermoneutrality. If this were the case then this underscores the importance of 
understanding the fundamental differences between the microbiomes of mice housed at room 
temperature and thermoneutrality, an area that has not yet been explored.  
The microbiome of mice on a high-fat diet is drastically different from that of mice on a low-fat 
normal diet (Ley et al., 2005) . Therefore, another further aspect yet to be explored is the role of 
the microbiome in high-fat diet fed mice. All studies listed above will therefore be performed on 
mice fed a high-fat diet. Is the reduced weight in Tsc1f/fCD11cCre mice  also dependent on the 
microbiome when mice are on a high-fat diet? And is this microbiome sufficient to transfer the 
phenotype of these mice housed at either thermoneutrality or room-temperature? In conclusion, 
this chapter highlights the important role diet and housing temperature play on metabolic and 
microbial phenotypes and mechanisms.  
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FIGURE LEGENDS 
Figure 3.1. Tsc1f/fCD11cCre mice on a high-fat diet and housed at thermoneutrality weigh 
less and consume less food than Tsc1f/f mice.  
(A) Change in body mass over time of mice placed on a high-fat diet at 6 weeks of age while 
housed at thermoneutrality (n=6-8 per genotype; analyzed by two-way ANOVA) (B) Dual-
energy X-ray absorptiometry of mice from (A) after 12 weeks of HFD (n=3-5 per genotype; 
analyzed by t-test).  (C-F) Metabolic analysis of food intake (C), oxygen consumption (D), RER 
(E) and total activity (F) of thermoneutrally housed mice after 12 weeks on a HFD (n=3 per 
genotype; analyzed by t-test or by two-way ANOVA).  
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Figure 3.1. Tsc1f/fCD11cCre mice on a high-fat diet and housed at thermoneutrality weigh less 
and consume less food than Tsc1f/f mice.  
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Figure 3.2. Thermoneutrality uncouples reduced weight gain from insulin intolerance and 
microbiome sufficiency in Tsc1f/fCD11cCre mice. 
(A) Change in body mass over time of mice placed on a high-fat diet while housed at 22°C (n=5 
per genotype; analyzed by two-way ANOVA). (B-C) Glucose-tolerance tests for mice on a high-
fat diet housed at room temperature (B) and thermoneutrality (C). Mice were fasted overnight 
and administered 1.5g/kg glucose. (n=4-5 per genotype; analyzed by two-way ANOVA). (D-E) 
Insulin-tolerance tests of mice on a high-fat diet housed at room temperature (D) and 
thermoneutrality (E) (n=4-5 per genotype; analyzed by two-way ANOVA).  (F) 13-week old 
body weight of Tsc1f/f or Tsc1f/fCD11cCre mice on a low-fat normal chow diet housed at either  
30°C or 22°C (n = 4-5 per genotype; analyzed by t-test). (G-H) % weight gain in C57BL/6J mice 
given stool from either Tsc1f/f or Tsc1f/fCD11cCre mice housed at 30°C (G) or 22°C  (H) (n=7-8 
per genotype; analyzed by t-test). 
 
 76 
 
Figure 3.2. Thermoneutrality uncouples reduced weight gain from insulin intolerance and 
microbiome sufficiency in Tsc1f/fCD11cCre mice. 
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Figure 3.3. Summary of the effects of housing temperature and diet on weight gain, insulin 
sensitivity and microbiome sufficiency phenotypes in Tsc1f/fCD11cCre mice relative to    
Tsc1f/fmice . 
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Figure 3.3. Summary of the effects of housing temperature and diet on weight gain, insulin 
sensitivity and microbiome sufficiency phenotypes in Tsc1f/fCD11cCre mice relative to    
Tsc1f/fmice . 
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Figure S3.1. Fasting times and glucose dosage do not restore glucose tolerance differences  
in Tsc1f/fCD11cCre mice. 
(A-B) Glucose-tolerance tests of mice on a high-fat diet housed at thermoneutrality. (A) Mice 
were fasted for 6 hours and administered 1.5g/kg glucose. (B) Mice were fasted for 6 hours and 
administered 1g/kg glucose (n=4-5 per genotype; analyzed by two-way ANOVA). 
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Figure S3.1. Fasting times and glucose dosage do not restore glucose tolerance differences  in 
Tsc1f/fCD11cCre mice. 
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Figure 3.4. Summary of known and potential housing temperature effects on the 
Tsc1f/fCD11cCre microbiome sufficiency to transfer reduced weight phenotype to C57BL/6J 
mice. 
 
 
  
30°C 22°C
DONOR STOOL 
RE
CI
PI
EN
T 
HO
ST
 
30
°C
22
°C
FUTURE DIRECTIONS FIGURE 3.2G-H 
30°C mice are “universal acceptors”
Donor and recipient temperatures 
need to match
Microbiome not mechanism at 
22°C
Microbiome suﬃcient to 

transfer phenotype.
Microbiome not suﬃcient 

to transfer phenotype.
Microbiome suﬃcient to transfer 
phenotype:
Microbiome not suﬃcient to transfer 
phenotype:
Microbiome suﬃcient to transfer 
phenotype:
Donor and recipient temperatures 
need to match
Microbiome not suﬃcient to transfer 
phenotype:
 82 
MATERIALS AND METHODS 
Animal studies 
Mice were maintained in the University of California San Francisco specific pathogen–free animal 
facility in accordance with the guidelines established by the Institutional Animal Care and Use 
Committee and Laboratory Animal Resource Center. Mice were housed either at 30°C after 
weaning or kept at 22°C in Darwin or Power Scientific environmental chambers under a 12-hr 
light:dark cycle. Tsc1f/f and CD11cCre mice were purchased from Jackson Laboratories, 
backcrossed onto C57BL/6J background (Nnt null) for 10 generations, and used to generate Tsc1f/f 
CD11cCre mice. Mice were fed normal chow diet (5053, Pico labs) or high fat diet (D12492i, 
Research Diets)  
Energy expenditure and body composition analysis 
Body composition (fat and lean mass) analysis were performed on anesthetized mice using Dual-
energy X-ray absorptiometry (DEXA). For measurement of energy expenditure, food intake, and 
locomotor activity, mice were placed in CLAMS (Columbus Instruments) cages that housed an 
environmental chamber set at 30°C. After acclimatization for one day, data on oxygen 
consumption, locomotor activity, and food intake was collected every 22 minutes. 
Glucose and insulin tolerance tests 
For glucose and insulin tolerance tests, mice were intraperitoneally injected with glucose (1 or 
1.5g/kg of body weight) after 6h or 14h fast or insulin (1U/kg of body weight) after 6h or overnight 
fast, and blood glucose was measured at regular intervals using tail blood. 
Fecal microbiota transplantation and Germ-free colonization 
Antibiotics (vancomycin hydrocholoride (5mg/ml), metronidazole (10mg/ml), ampicillin 
(10mg/ml), and neomycin trisulfate salt hydrate (10 mg/ml)) were administered to mice in drinking 
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water for 24 hours. Fresh feces were collected from three to four mice in 0.1mg/ µL PBS 
(supplemented with 0.05% cysteine, 1µg/ml vitamin K, 15% glycerol, 5 µg/ml hemin), gently 
homogenized, pooled, and passed through a 100-µm cell strainer. The suspension was 
administered by oral gavage six days a week in mice treated with antibiotics. 
Statistical analysis 
Data were analyzed using Prism (GraphPad) and are presented as mean±SEM. Statistical 
significance was determined using the unpaired two-tailed Student’s t test for single variables and 
two-way ANOVA followed by Bonferroni post-tests for two variables. A p-value of <0.05 was 
considered to be statistically significant. 
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CHAPTER 4. 
CONCLUDING REMARKS AND FUTURE DIRECTIONS 
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Overall this body of work shows that nutrient sensing in immune cells regulates systemic 
metabolism through the microbiome and that this interaction is influenced by housing 
temperature and diet.  
This body of work raises some interesting questions. From Chapter 2, one is left wondering what 
are the mechanisms by which Lactobacillus johnsonii Q1-7 controls food intake and weight gain. 
To address this we will first need to understand if Lactobacillus johnsonii Q1-7 uniquely rescues 
Tsc1f/fCD11cCre mice. This can be done by gavaging different members of the Lactobacillus 
genus and classifying them into groups that are either able to rescue or to not rescue the 
phenotype. One can then perform comparative genomic analysis on species in either group to 
understand what is unique and therefore have a better understanding of the properties of 
Lactobacillus responsible for rescuing the weight and food consumption differences in 
Tsc1f/fCD11cCre mice. In conjunction one can perform metabolomics on the serum of  
Tsc1f/fCD11cCre mice before and after rescue by Lactobacillus johnsonii Q1-7 to understand 
what metabolites may be changing pre and post rescue and if any of those are directly made by 
Lactobacillus based on the genome analysis. The second major question is exactly how CD11c+ 
cells are influencing IgA binding to Lactobacillus johnsonii Q1-7. In order to assess this the 
Tsc1f/fCD11cCre and Tsc1f/f mice would have to re-derived under germ-free conditions and 
mono-colonized with Lactobacillus johnsonii Q1-7. IgA binding can then be analyzed under 
these conditions more specifically.  
From Chapter 3 one major question is how the microbiome changes under different housing 
conditions – our work suggests that the Tsc1f/fCD11cCre mice microbiome changes with 
housing temperature but this needs to be analyzed. To assess this, littermate controls from 
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Tsc1f/fCD11cCre and Tsc1f/f mice would be bred at room-temperature and then one cohort 
moved to thermoneutrality and 16S sequencing performed on stool weekly to assess how the 
microbiome changes with housing temperature over time. In addition the other major question 
that this work raises is how the rescue of this phenotype performs under high-fat diet conditions 
– what is different or similar between different dietary conditions? 
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